TreeWAS – Variant ID: rs11255841

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D12.5 Sigmoid colon	0.000	0.000	1.000
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.000	0.000	1.000
D12.3 Transverse colon	0.000	0.000	1.000
D12.8 Rectum	0.000	0.001	0.999
D12.6 Colon, unspecified	0.000	0.005	0.995
D12.0 Caecum	0.000	0.012	0.988
D12.2 Ascending colon	0.000	0.020	0.980
D12.4 Descending colon	0.000	0.030	0.970
D12.7 Rectosigmoid junction	0.000	0.038	0.962
D12.1 Appendix	0.000	0.315	0.685
C20 Malignant neoplasm of rectum	0.000	0.345	0.655
D12.9 Anus and anal canal	0.000	0.377	0.623
M65.34 Trigger finger-Hand	0.000	0.934	0.066
E10 Insulin-dependent diabetes mellitus	0.000	0.946	0.054
E10.3 With ophthalmic complications	0.000	0.947	0.053
E10.5 With peripheral circulatory complications	0.000	0.948	0.052
E10.9 Without complications	0.000	0.948	0.052
E10.4 With neurological complications	0.000	0.952	0.048
Z86.0 Personal history of other neoplasms	0.000	0.952	0.048
E10.2 With renal complications	0.000	0.953	0.047
E10.8 With unspecified complications	0.000	0.957	0.043
E10.0 With coma	0.000	0.960	0.040
E10.6 With other specified complications	0.000	0.961	0.039
E10.7 With multiple complications	0.000	0.961	0.039
C45.0 Mesothelioma of pleura	0.000	0.969	0.031
C15-C26 Malignant neoplasms of digestive organs	0.000	0.969	0.031
C26.0 Intestinal tract, part unspecified	0.000	0.969	0.031
C26 Malignant neoplasm of other and ill-defined digestive organs	0.000	0.969	0.031
C45.9 Mesothelioma, unspecified	0.000	0.970	0.030
C45 Mesothelioma	0.000	0.970	0.030
M65.3 Trigger finger	0.000	0.971	0.029
C19 Malignant neoplasm of rectosigmoid junction	0.000	0.973	0.027
C45.7 Mesothelioma of other sites	0.000	0.973	0.027
C26.8 Overlapping lesion of digestive system	0.000	0.978	0.022
C26.1 Spleen	0.000	0.978	0.022
C45.2 Mesothelioma of pericardium	0.000	0.978	0.022
C45.1 Mesothelioma of peritoneum	0.000	0.978	0.022
C18 Malignant neoplasm of colon	0.000	0.978	0.022
C26.9 Ill-defined sites within the digestive system	0.000	0.978	0.022
M65.39 Trigger finger-Site unspec	0.000	0.979	0.021
M65.38 Trigger finger-Other	0.000	0.979	0.021
M65.37 Trigger finger-Ankle/foot	0.000	0.979	0.021
M65.36 Trigger finger-Lower leg	0.000	0.979	0.021
M65.35 Trigger finger-Pelvic/thigh	0.000	0.979	0.021
M65.33 Trigger finger-Forearm	0.000	0.979	0.021
M65.32 Trigger finger-Upper arm	0.000	0.979	0.021
M65.31 Trigger finger-Shldr region	0.000	0.979	0.021
M65.30 Trigger finger-Mult sites	0.000	0.979	0.021
C18.7 Sigmoid colon	0.000	0.979	0.021
C23 Malignant neoplasm of gallbladder	0.000	0.980	0.020
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.000	0.981	0.019
C18.6 Descending colon	0.000	0.981	0.018
C18.4 Transverse colon	0.000	0.983	0.017
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.000	0.983	0.017
C24.0 Extrahepatic bile duct	0.000	0.983	0.017
D37.5 Rectum	0.000	0.983	0.017
C25 Malignant neoplasm of pancreas	0.000	0.984	0.016
C18.9 Colon, unspecified	0.000	0.984	0.016
D37.7 Other digestive organs	0.000	0.984	0.016
C18.1 Appendix	0.000	0.985	0.015
C17 Malignant neoplasm of small intestine	0.000	0.985	0.015
C18.8 Overlapping lesion of colon	0.000	0.985	0.015
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.000	0.985	0.015
C18.3 Hepatic flexure	0.000	0.985	0.015
C24.8 Overlapping lesion of biliary tract	0.000	0.986	0.014
K50.0 Crohn's disease of small intestine	0.014	0.986	0.000
C18.0 Caecum	0.000	0.986	0.014
D37.1 Stomach	0.000	0.986	0.014
D37.4 Colon	0.000	0.986	0.014
E10.1 With ketoacidosis	0.000	0.987	0.013
C22.9 Liver, unspecified	0.000	0.987	0.013
C25.7 Other parts of pancreas	0.000	0.987	0.013
C22.7 Other specified carcinomas of liver	0.000	0.987	0.012
C22.4 Other sarcomas of liver	0.000	0.987	0.012
C22.3 Angiosarcoma of liver	0.000	0.987	0.012
C22.2 Hepatoblastoma	0.000	0.987	0.012
C25.4 Endocrine pancreas	0.000	0.987	0.012
I72.4 Aneurysm of artery of lower extremity	0.000	0.988	0.012
C25.0 Head of pancreas	0.000	0.988	0.012
C25.2 Tail of pancreas	0.000	0.988	0.012
C24.9 Biliary tract, unspecified	0.000	0.988	0.012
C25.8 Overlapping lesion of pancreas	0.000	0.988	0.012
K50.1 Crohn's disease of large intestine	0.012	0.988	0.000
K50 Crohn's disease [regional enteritis]	0.012	0.988	0.000
C17.9 Small intestine, unspecified	0.000	0.988	0.011
C25.1 Body of pancreas	0.000	0.988	0.011
N36.2 Urethral caruncle	0.011	0.989	0.000
C21 Malignant neoplasm of anus and anal canal	0.001	0.989	0.011
C17.8 Overlapping lesion of small intestine	0.000	0.989	0.011
C17.3 Meckel's diverticulum	0.000	0.989	0.011
C17.2 Ileum	0.000	0.989	0.010
D37.0 Lip, oral cavity and pharynx	0.000	0.989	0.011
C25.3 Pancreatic duct	0.000	0.989	0.010
D37.6 Liver, gallbladder and bile ducts	0.000	0.989	0.010
N80.0 Endometriosis of uterus	0.000	0.990	0.010
K50.9 Crohn's disease, unspecified	0.010	0.990	0.000
C22.1 Intrahepatic bile duct carcinoma	0.000	0.990	0.010
C22.0 Liver cell carcinoma	0.000	0.990	0.010
D37.2 Small intestine	0.000	0.990	0.009
C17.1 Jejunum	0.000	0.990	0.009
C16 Malignant neoplasm of stomach	0.000	0.991	0.009
I72 Other aneurysm	0.000	0.991	0.009
C21.2 Cloacogenic zone	0.001	0.992	0.008
K50.8 Other Crohn's disease	0.008	0.992	0.000
D37.3 Appendix	0.000	0.992	0.008
C24.1 Ampulla of Vater	0.001	0.992	0.007
C18.5 Splenic flexure	0.000	0.992	0.007
C21.8 Overlapping lesion of rectum, anus and anal canal	0.001	0.992	0.007
I72.2 Aneurysm of renal artery	0.000	0.993	0.007
C18.2 Ascending colon	0.000	0.993	0.007
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.000	0.993	0.007
I72.9 Aneurysm of unspecified site	0.000	0.993	0.007
C16.3 Pyloric antrum	0.000	0.993	0.007
C21.1 Anal canal	0.001	0.993	0.006
D37.9 Digestive organ, unspecified	0.000	0.993	0.007
I72.3 Aneurysm of iliac artery	0.000	0.993	0.007
I72.0 Aneurysm of carotid artery	0.000	0.993	0.007
C16.2 Body of stomach	0.000	0.993	0.007
C16.0 Cardia	0.000	0.993	0.007
C17.0 Duodenum	0.001	0.993	0.006
C16.8 Overlapping lesion of stomach	0.000	0.994	0.006
C16.4 Pylorus	0.000	0.994	0.006
I72.6 Aneurysm and dissection of vertebral artery	0.000	0.994	0.006
I72.5 Aneurysm and dissection of other precerebral arteries	0.000	0.994	0.006
I72.1 Aneurysm of artery of upper extremity	0.000	0.994	0.006
D03.5 Melanoma in situ of trunk	0.006	0.994	0.000
Z71.8 Other specified counselling	0.000	0.994	0.006
C16.5 Lesser curvature of stomach, unspecified	0.000	0.994	0.006
Z09.0 Follow-up examination after surgery for other conditions	0.000	0.994	0.006
H53.1 Subjective visual disturbances	0.000	0.994	0.006
K62.1 Rectal polyp	0.000	0.994	0.006
C25.9 Pancreas, unspecified	0.000	0.994	0.006
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.006	0.994	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.994	0.006
I72.8 Aneurysm of other specified arteries	0.000	0.994	0.006
C16.1 Fundus of stomach	0.000	0.994	0.005
D03 Melanoma in situ	0.006	0.994	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.000	0.995	0.005
C46 Kaposi's sarcoma	0.000	0.995	0.005
C16.6 Greater curvature of stomach, unspecified	0.000	0.995	0.005
Z22.3 Carrier of other specified bacterial diseases	0.000	0.995	0.005
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.000	0.995	0.005
U51 Admission status on psychiatric patients	0.000	0.995	0.005
C71.1 Frontal lobe	0.000	0.995	0.005
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.995	0.005
D03.6 Melanoma in situ of upper limb, including shoulder	0.005	0.995	0.000
D03.8 Melanoma in situ of other sites	0.005	0.995	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.005	0.995	0.000
X10.0 Home	0.005	0.995	0.000
C71 Malignant neoplasm of brain	0.000	0.995	0.005
D04.4 Skin of scalp and neck	0.005	0.995	0.000
C15 Malignant neoplasm of oesophagus	0.000	0.995	0.005
D03.0 Melanoma in situ of lip	0.005	0.995	0.000
C71.0 Cerebrum, except lobes and ventricles	0.000	0.995	0.005
D03.4 Melanoma in situ of scalp and neck	0.004	0.996	0.000
C48.0 Retroperitoneum	0.000	0.996	0.004
D03.7 Melanoma in situ of lower limb, including hip	0.004	0.996	0.000
D04.3 Skin of other and unspecified parts of face	0.004	0.996	0.000
C71.2 Temporal lobe	0.000	0.996	0.004
C71.9 Brain, unspecified	0.000	0.996	0.004
D03.9 Melanoma in situ, unspecified	0.004	0.996	0.000
C46.9 Kaposi's sarcoma, unspecified	0.000	0.996	0.004
C46.8 Kaposi's sarcoma of multiple organs	0.000	0.996	0.004
C46.7 Kaposi's sarcoma of other sites	0.000	0.996	0.004
C46.3 Kaposi's sarcoma of lymph nodes	0.000	0.996	0.004
C46.2 Kaposi's sarcoma of palate	0.000	0.996	0.004
C46.1 Kaposi's sarcoma of soft tissue	0.000	0.996	0.004
C46.0 Kaposi's sarcoma of skin	0.000	0.996	0.004
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.000	0.996	0.004
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.000	0.996	0.004
C47.6 Peripheral nerves of trunk, unspecified	0.000	0.996	0.004
C47.5 Peripheral nerves of pelvis	0.000	0.996	0.004
C47.4 Peripheral nerves of abdomen	0.000	0.996	0.004
C47.3 Peripheral nerves of thorax	0.000	0.996	0.004
C47.2 Peripheral nerves of lower limb, including hip	0.000	0.996	0.004
C47.1 Peripheral nerves of upper limb, including shoulder	0.000	0.996	0.004
C47.0 Peripheral nerves of head, face and neck	0.000	0.996	0.004
C21.0 Anus, unspecified	0.002	0.996	0.002
Z71.3 Dietary counselling and surveillance	0.000	0.996	0.004
D03.2 Melanoma in situ of ear and external auricular canal	0.004	0.996	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.000	0.996	0.004
Z71.1 Person with feared complaint in whom no diagnosis is made	0.000	0.996	0.004
C48.1 Specified parts of peritoneum	0.000	0.996	0.004
M95.0 Acquired deformity of nose	0.000	0.996	0.004
D04 Carcinoma in situ of skin	0.004	0.996	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.996	0.004
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.000	0.996	0.004
Z22 Carrier of infectious disease	0.000	0.996	0.004
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.996	0.004
C71.4 Occipital lobe	0.000	0.996	0.004
C71.3 Parietal lobe	0.000	0.996	0.004
C71.6 Cerebellum	0.000	0.996	0.004
C71.5 Cerebral ventricle	0.000	0.996	0.004
D04.6 Skin of upper limb, including shoulder	0.004	0.996	0.000
H73.8 Other specified disorders of tympanic membrane	0.004	0.996	0.000
M67.1 Other contracture of tendon (sheath)	0.004	0.996	0.000
C71.8 Overlapping lesion of brain	0.000	0.996	0.004
C15.8 Overlapping lesion of oesophagus	0.000	0.996	0.003
C15.2 Abdominal part of oesophagus	0.000	0.996	0.003
C15.1 Thoracic part of oesophagus	0.000	0.996	0.003
C48.2 Peritoneum, unspecified	0.000	0.996	0.003
C71.7 Brain stem	0.000	0.996	0.003
Z71.4 Alcohol abuse counselling and surveillance	0.000	0.996	0.003
U80 Agent resistant to penicillin and related antibiotics	0.000	0.996	0.004
D04.2 Skin of ear and external auricular canal	0.003	0.997	0.000
K13.0 Diseases of lips	0.003	0.997	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.003	0.997	0.000
C15.0 Cervical part of oesophagus	0.000	0.997	0.003
J38.3 Other diseases of vocal cords	0.003	0.997	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.997	0.003
D00-D09 In situ neoplasms	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.997	0.003
U88 Agent resistant to multiple antibiotics	0.000	0.997	0.003
X10 Contact with hot drinks, food, fats and cooking oils	0.003	0.997	0.000
C15.3 Upper third of oesophagus	0.000	0.997	0.003
Z22.1 Carrier of other intestinal infectious diseases	0.000	0.997	0.003
U80.1 Methicillin resistant agent	0.000	0.997	0.003
D04.8 Skin of other sites	0.003	0.997	0.000
D04.0 Skin of lip	0.003	0.997	0.000
K35.0 Acute appendicitis with generalised peritonitis	0.000	0.997	0.003
Z22.5 Carrier of viral hepatitis	0.000	0.997	0.003
Z71.7 Human immunodeficiency virus [HIV] counselling	0.000	0.997	0.003
Z71.5 Drug abuse counselling and surveillance	0.000	0.997	0.003
Z71.0 Person consulting on behalf of another person	0.000	0.997	0.003
Z22.9 Carrier of infectious disease, unspecified	0.000	0.997	0.003
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.000	0.997	0.003
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.000	0.997	0.003
Z22.2 Carrier of diphtheria	0.000	0.997	0.003
Z22.0 Carrier of typhoid	0.000	0.997	0.003
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.003	0.997	0.000
C16.9 Stomach, unspecified	0.000	0.997	0.003
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.997	0.003
D00.1 Oesophagus	0.003	0.997	0.000
D06 Carcinoma in situ of cervix uteri	0.003	0.997	0.000
M65 Synovitis and tenosynovitis	0.000	0.997	0.003
U50 Level of care administered to neonates	0.000	0.997	0.003
U07 Emergency use of U07	0.000	0.997	0.003
U06 Emergency use of U06	0.000	0.997	0.003
U04 Severe acute respiratory syndrome [SARS]	0.000	0.997	0.003
U52 First in a series of a regular day/night admissions	0.000	0.997	0.003
K29.5 Chronic gastritis, unspecified	0.003	0.997	0.000
D06.9 Cervix, unspecified	0.003	0.997	0.000
Z22.8 Carrier of other infectious diseases	0.000	0.997	0.003
C15.4 Middle third of oesophagus	0.000	0.997	0.003
D04.9 Skin, unspecified	0.003	0.997	0.000
D04.1 Skin of eyelid, including canthus	0.003	0.997	0.000
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status	0.000	0.997	0.003
Z71.2 Person consulting for explanation of investigation findings	0.000	0.997	0.003
D23.3 Skin of other and unspecified parts of face	0.003	0.997	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.003	0.997	0.000
Chapter XXII Codes for special purposes	0.000	0.997	0.003
J93.8 Other pneumothorax	0.000	0.997	0.003
T21.2 Burn of second degree of trunk	0.003	0.997	0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.000	0.997	0.003
C49 Malignant neoplasm of other connective and soft tissue	0.000	0.997	0.003
U89 Agent resistant to other and unspecified antibiotics	0.000	0.997	0.003
X10.9 Unspecified place	0.002	0.997	0.000
X10.8 Other specified place	0.002	0.997	0.000
X10.7 Farm	0.002	0.997	0.000
X10.6 Industrial and construction area	0.002	0.997	0.000
X10.5 Trade and service area	0.002	0.997	0.000
X10.4 Street and highway	0.002	0.997	0.000
X10.3 Sports and athletics area	0.002	0.997	0.000
X10.2 School, other institution and public administrative area	0.002	0.997	0.000
X10.1 Residential institution	0.002	0.997	0.000
U89.8 Agent resistant to other single specified antibiotic	0.000	0.997	0.003
S92.50 Fracture of other toe (closed)	0.002	0.997	0.000
D00.2 Stomach	0.002	0.997	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.000	0.997	0.003
U84 Resistance to other antimicrobial drugs	0.000	0.997	0.002
U83 Resistance to other antibiotics	0.000	0.997	0.002
U82 Resistance to betalactam antibiotics	0.000	0.997	0.002
U85 Resistance to antineoplastic drugs	0.000	0.997	0.002
D06.7 Other parts of cervix	0.002	0.997	0.000
D06.1 Exocervix	0.002	0.997	0.000
M65.0 Abscess of tendon sheath	0.000	0.997	0.002
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.997	0.002
U06.9 Emergency use of U06.9	0.000	0.997	0.002
U06.8 Emergency use of U06.8	0.000	0.997	0.002
U06.7 Emergency use of U06.7	0.000	0.997	0.002
U06.6 Emergency use of U06.6	0.000	0.997	0.002
U06.5 Emergency use of U06.5	0.000	0.997	0.002
U06.4 Emergency use of U06.4	0.000	0.997	0.002
U06.3 Emergency use of U06.3	0.000	0.997	0.002
U06.2 Emergency use of U06.2	0.000	0.997	0.002
U06.1 Emergency use of U06.1	0.000	0.997	0.002
U06.0 Emergency use of U06.0	0.000	0.997	0.002
U07.9 Emergency use of U07.9	0.000	0.997	0.002
U07.8 Emergency use of U07.8	0.000	0.997	0.002
U07.7 Emergency use of U07.7	0.000	0.997	0.002
U07.6 Emergency use of U07.6	0.000	0.997	0.002
U07.5 Emergency use of U07.5	0.000	0.997	0.002
U07.4 Emergency use of U07.4	0.000	0.997	0.002
U07.3 Emergency use of U07.3	0.000	0.997	0.002
U07.2 Emergency use of U07.2	0.000	0.997	0.002
U07.1 Emergency use of U07.1	0.000	0.997	0.002
U07.0 Emergency use of U07.0	0.000	0.997	0.002
U50.9 Inquest Adjourned Death	0.000	0.997	0.002
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.997	0.002
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.997	0.002
U50.1 Level of care administered to neonates (Special Care)	0.000	0.997	0.002
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.997	0.002
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.998	0.002
D02.0 Larynx	0.002	0.998	0.000
T21 Burn and corrosion of trunk	0.002	0.998	0.000
D00.0 Lip, oral cavity and pharynx	0.002	0.998	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.002	0.998	0.000
T21.3 Burn of third degree of trunk	0.002	0.998	0.000
Z09.9 Follow-up examination after unspecified treatment for other conditions	0.000	0.998	0.002
C77.4 Inguinal and lower limb lymph nodes	0.002	0.998	0.000
M65.1 Other infective (teno)synovitis	0.000	0.998	0.002
E10-E14 Diabetes mellitus	0.000	0.998	0.002
D06.0 Endocervix	0.002	0.998	0.000
M65.2 Calcific tendinitis	0.000	0.998	0.002
K90.0 Coeliac disease	0.000	0.998	0.002
S92.5 Fracture of other toe	0.002	0.998	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.002	0.998	0.000
T20.0 Burn of unspecified degree of head and neck	0.002	0.998	0.000
Z29.8 Other specified prophylactic measures	0.000	0.998	0.002
D02.4 Respiratory system, unspecified	0.002	0.998	0.000
D02.3 Other parts of respiratory system	0.002	0.998	0.000
D02.1 Trachea	0.002	0.998	0.000
D02.2 Bronchus and lung	0.002	0.998	0.000
Z24 Need for immunisation against certain single viral diseases	0.000	0.998	0.002
C49.5 Connective and soft tissue of pelvis	0.000	0.998	0.002
K63.5 Polyp of colon	0.000	0.998	0.002
M65.8 Other synovitis and tenosynovitis	0.000	0.998	0.002
S56.4 Injury of extensor muscle and tendon of other finger(s) at forearm level	0.002	0.998	0.000
Z28 Immunisation not carried out	0.000	0.998	0.002
Z27 Need for immunisation against combinations of infectious diseases	0.000	0.998	0.002
Z26 Need for immunisation against other single infectious diseases	0.000	0.998	0.002
Z25 Need for immunisation against other single viral diseases	0.000	0.998	0.002
Z23 Need for immunisation against single bacterial diseases	0.000	0.998	0.002
Z20 Contact with and exposure to communicable diseases	0.000	0.998	0.002
C49.8 Overlapping lesion of connective and soft tissue	0.000	0.998	0.002
C49.6 Connective and soft tissue of trunk, unspecified	0.000	0.998	0.002
S92.2 Fracture of other tarsal bone(s)	0.002	0.998	0.000
X11.0 Home	0.002	0.998	0.000
S92.40 Fracture of great toe (closed)	0.002	0.998	0.000
D04.5 Skin of trunk	0.002	0.998	0.000
K08.8 Other specified disorders of teeth and supporting structures	0.000	0.998	0.002
S92.4 Fracture of great toe	0.002	0.998	0.000
T21.0 Burn of unspecified degree of trunk	0.002	0.998	0.000
Z29.0 Isolation	0.000	0.998	0.002
Z98.1 Arthrodesis status	0.000	0.998	0.002
M65.84 Other synovitis and tenosynovitis (Hand)	0.000	0.998	0.002
H73 Other disorders of tympanic membrane	0.002	0.998	0.000
X11 Contact with hot tap-water	0.002	0.998	0.000
Z29 Need for other prophylactic measures	0.000	0.998	0.002
S92.51 Fracture of other toe (open)	0.002	0.998	0.000
C49.4 Connective and soft tissue of abdomen	0.000	0.998	0.002
X10-X19 Contact with heat and hot substances	0.002	0.998	0.000
S92.70 Multiple fractures of foot (closed)	0.002	0.998	0.000
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.002	0.998	0.000
C49.9 Connective and soft tissue, unspecified	0.000	0.998	0.002
O36.9 Maternal care for foetal problem, unspecified	0.000	0.998	0.002
U82.9 Resistance to betalactam antibiotics, unspecified	0.000	0.998	0.002
U82.8 Resistance to other betalactam antibiotics	0.000	0.998	0.002
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.000	0.998	0.002
U82.1 Resistance to methicillin	0.000	0.998	0.002
U82.0 Resistance to penicillin	0.000	0.998	0.002
U83.9 Resistance to unspecified antibiotic	0.000	0.998	0.002
U83.8 Resistance to other single specified antibiotic	0.000	0.998	0.002
U83.7 Resistance to multiple antibiotics	0.000	0.998	0.002
U83.2 Resistance to quinolones	0.000	0.998	0.002
U83.1 Resistance to other vancomycin related antibiotics	0.000	0.998	0.002
U83.0 Resistance to vancomycin	0.000	0.998	0.002
U84.9 Resistance to unspecified antimicrobial drugs	0.000	0.998	0.002
U84.8 Resistance to other specified antimicrobial drug	0.000	0.998	0.002
U84.7 Resistance to multiple antimicrobial drugs	0.000	0.998	0.002
U84.3 Resistance to tuberculostatic drug(s)	0.000	0.998	0.002
U84.2 Resistance to antiviral drug(s)	0.000	0.998	0.002
U84.1 Resistance to antifungal drug(s)	0.000	0.998	0.002
U84.0 Resistance to antiparasitic drug(s)	0.000	0.998	0.002
D09 Carcinoma in situ of other and unspecified sites	0.002	0.998	0.000
M65.09 Abscess of tendon sheath (Site unspecified)	0.000	0.998	0.002
M65.08 Abscess of tendon sheath (Other)	0.000	0.998	0.002
M65.07 Abscess of tendon sheath (Ankle and foot)	0.000	0.998	0.002
M65.06 Abscess of tendon sheath (Lower leg)	0.000	0.998	0.002
M65.05 Abscess of tendon sheath (Pelvic region and thigh)	0.000	0.998	0.002
M65.04 Abscess of tendon sheath (Hand)	0.000	0.998	0.002
M65.03 Abscess of tendon sheath (Forearm)	0.000	0.998	0.002
M65.02 Abscess of tendon sheath (Upper arm)	0.000	0.998	0.002
M65.01 Abscess of tendon sheath (Shoulder region)	0.000	0.998	0.002
M65.00 Abscess of tendon sheath (Multiple sites)	0.000	0.998	0.002
U89.9 Agent resistant to unspecified antibiotic	0.000	0.998	0.002
N70.1 Chronic salpingitis and oophoritis	0.000	0.998	0.002
S92.7 Multiple fractures of foot	0.002	0.998	0.000
T21.7 Corrosion of third degree of trunk	0.002	0.998	0.000
T21.6 Corrosion of second degree of trunk	0.002	0.998	0.000
T21.5 Corrosion of first degree of trunk	0.002	0.998	0.000
T21.4 Corrosion of unspecified degree of trunk	0.002	0.998	0.000
S92 Fracture of foot, except ankle	0.002	0.998	0.000
S92.41 Fracture of great toe (open)	0.002	0.998	0.000
H65.3 Chronic mucoid otitis media	0.002	0.998	0.000
M65.19 Other infective (teno)synovitis (Site unspecified)	0.000	0.998	0.002
M65.18 Other infective (teno)synovitis (Other)	0.000	0.998	0.002
M65.17 Other infective (teno)synovitis (Ankle and foot)	0.000	0.998	0.002
M65.16 Other infective (teno)synovitis (Lower leg)	0.000	0.998	0.002
M65.15 Other infective (teno)synovitis (Pelvic region and thigh)	0.000	0.998	0.002
M65.13 Other infective (teno)synovitis (Forearm)	0.000	0.998	0.002
M65.12 Other infective (teno)synovitis (Upper arm)	0.000	0.998	0.002
M65.11 Other infective (teno)synovitis (Shoulder region)	0.000	0.998	0.002
M65.10 Other infective (teno)synovitis (Multiple sites)	0.000	0.998	0.002
E12 Malnutrition-related diabetes mellitus	0.000	0.998	0.002
J93 Pneumothorax	0.000	0.998	0.002
M65.29 Calcific tendinitis (Site unspecified)	0.000	0.998	0.002
M65.28 Calcific tendinitis (Other)	0.000	0.998	0.002
M65.27 Calcific tendinitis (Ankle and foot)	0.000	0.998	0.002
M65.26 Calcific tendinitis (Lower leg)	0.000	0.998	0.002
M65.25 Calcific tendinitis (Pelvic region and thigh)	0.000	0.998	0.002
M65.24 Calcific tendinitis (Hand)	0.000	0.998	0.002
M65.23 Calcific tendinitis (Forearm)	0.000	0.998	0.002
M65.22 Calcific tendinitis (Upper arm)	0.000	0.998	0.002
M65.20 Calcific tendinitis (Multiple sites)	0.000	0.998	0.002
C49.3 Connective and soft tissue of thorax	0.000	0.998	0.002
C49.1 Connective and soft tissue of upper limb, including shoulder	0.000	0.998	0.002
M65.81 Other synovitis and tenosynovitis (Shoulder region)	0.000	0.998	0.002
D01.9 Digestive organ, unspecified	0.002	0.998	0.000
D01.7 Other specified digestive organs	0.002	0.998	0.000
D01.5 Liver, gallbladder and bile ducts	0.002	0.998	0.000
D01.4 Other and unspecified parts of intestine	0.002	0.998	0.000
D01.1 Rectosigmoid junction	0.002	0.998	0.000
U80.0 Penicillin resistant agent	0.000	0.998	0.002
Z24.5 Need for immunisation against rubella alone	0.000	0.998	0.002
X16 Contact with hot heating appliances, radiators and pipes	0.002	0.998	0.000
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.000	0.998	0.002
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.002	0.998	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.002	0.998	0.000
Z71.6 Tobacco abuse counselling	0.000	0.998	0.002
B00.9 Herpesviral infection, unspecified	0.002	0.998	0.000
T21.1 Burn of first degree of trunk	0.002	0.998	0.000
Z24.6 Need for immunisation against viral hepatitis	0.000	0.998	0.002
Z24.4 Need for immunisation against measles alone	0.000	0.998	0.002
Z24.3 Need for immunisation against yellow fever	0.000	0.998	0.002
Z24.2 Need for immunisation against rabies	0.000	0.998	0.002
Z24.1 Need for immunisation against arthropod-borne viral encephalitis	0.000	0.998	0.002
Z24.0 Need for immunisation against poliomyelitis	0.000	0.998	0.002
M65.89 Other synovitis and tenosynovitis (Site unspecified)	0.000	0.998	0.002
M65.88 Other synovitis and tenosynovitis (Other)	0.000	0.998	0.002
M65.85 Other synovitis and tenosynovitis (Pelvic region and thigh)	0.000	0.998	0.002
M65.82 Other synovitis and tenosynovitis (Upper arm)	0.000	0.998	0.002
M65.80 Other synovitis and tenosynovitis (Multiple sites)	0.000	0.998	0.002
Z20.9 Contact with and exposure to unspecified communicable disease	0.000	0.998	0.002
Z20.8 Contact with and exposure to other communicable diseases	0.000	0.998	0.002
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations	0.000	0.998	0.002
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]	0.000	0.998	0.002
Z20.5 Contact with and exposure to viral hepatitis	0.000	0.998	0.002
Z20.4 Contact with and exposure to rubella	0.000	0.998	0.002
Z20.3 Contact with and exposure to rabies	0.000	0.998	0.002
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission	0.000	0.998	0.002
Z20.1 Contact with and exposure to tuberculosis	0.000	0.998	0.002
Z20.0 Contact with and exposure to intestinal infectious diseases	0.000	0.998	0.002
Z23.8 Need for immunisation against other single bacterial diseases	0.000	0.998	0.002
Z23.7 Need for immunisation against pertussis alone	0.000	0.998	0.002
Z23.6 Need for immunisation against diphtheria alone	0.000	0.998	0.002
Z23.5 Need for immunisation against tetanus alone	0.000	0.998	0.002
Z23.4 Need for immunisation against tularaemia	0.000	0.998	0.002
Z23.3 Need for immunisation against plague	0.000	0.998	0.002
Z23.2 Need for immunisation against tuberculosis [BCG]	0.000	0.998	0.002
Z23.1 Need for immunisation against typhoid-paratyphoid alone [TAB]	0.000	0.998	0.002
Z23.0 Need for immunisation against cholera alone	0.000	0.998	0.002
Z25.8 Need for immunisation against other specified single viral diseases	0.000	0.998	0.002
Z25.1 Need for immunisation against influenza	0.000	0.998	0.002
Z25.0 Need for immunisation against mumps alone	0.000	0.998	0.002
Z26.9 Need for immunisation against unspecified infectious disease	0.000	0.998	0.002
Z26.8 Need for immunisation against other specified single infectious diseases	0.000	0.998	0.002
Z26.0 Need for immunisation against leishmaniasis	0.000	0.998	0.002
Z27.9 Need for immunisation against unspecified combinations of infectious diseases	0.000	0.998	0.002
Z27.8 Need for immunisation against other combinations of infectious diseases	0.000	0.998	0.002
Z27.4 Need for immunisation against measles-mumps-rubella [MMR]	0.000	0.998	0.002
Z27.3 Need for immunisation against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio]	0.000	0.998	0.002
Z27.2 Need for immunisation against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB]	0.000	0.998	0.002
Z27.1 Need for immunisation against diphtheria-tetanus-pertussis, combined [DTP]	0.000	0.998	0.002
Z27.0 Need for immunisation against cholera with typhoid-paratyphoid [cholera + TAB]	0.000	0.998	0.002
Z28.9 Immunisation not carried out for unspecified reason	0.000	0.998	0.002
Z28.8 Immunisation not carried out for other reasons	0.000	0.998	0.002
Z28.2 Immunisation not carried out because of patient's decision for other and unspecified reasons	0.000	0.998	0.002
Z28.1 Immunisation not carried out because of patient's decision for reasons of belief or group pressure	0.000	0.998	0.002
Z28.0 Immunisation not carried out because of contraindication	0.000	0.998	0.002
T20 Burn and corrosion of head and neck	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
M65.14 Other infective (teno)synovitis (Hand)	0.000	0.998	0.002
C49.0 Connective and soft tissue of head, face and neck	0.000	0.998	0.002
D01.3 Anus and anal canal	0.002	0.998	0.000
D04.7 Skin of lower limb, including hip	0.002	0.998	0.000
D09.9 Carcinoma in situ, unspecified	0.002	0.998	0.000
K92.9 Disease of digestive system, unspecified	0.000	0.998	0.002
M65.4 Radial styloid tenosynovitis [de Quervain]	0.000	0.998	0.002
O36.8 Maternal care for other specified foetal problems	0.000	0.998	0.002
T25 Burn and corrosion of ankle and foot	0.002	0.998	0.000
S92.21 Fracture of other tarsal bone(s) (open)	0.002	0.998	0.000
S02.4 Fracture of malar and maxillary bones	0.002	0.998	0.000
M65.21 Calcific tendinitis (Shoulder region)	0.000	0.998	0.001
D01.0 Colon	0.002	0.998	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.998	0.001
D48.1 Connective and other soft tissue	0.002	0.998	0.000
J93.1 Other spontaneous pneumothorax	0.000	0.998	0.002
X16.0 Home	0.002	0.998	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations